§ Funding Round
Series B funding round for Mineralys Therapeutics raising $120M in June 2022
Series B funding round for Mineralys Therapeutics raising $120M in June 2022
| Investor | Firm Type | Partner |
|---|---|---|
Access Biotechnology | — | — |
Andera PartnersLEAD | Organization | — |
Arix Bioscience | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Catalys Pacific | — | — |
HBM Healthcare Investments | — | — |
HealthCor | — | — |
derek diroccoLEAD | Angel | derek dirocco |
| Organization | — | |
| Organization | — | |
Samsara BioCapital | — | — |
| Organization | — | |
SR One | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$169.5M
Top Valuation
-
Mineralys Therapeutics raised $120M in a Series B round.
The round was announced on 06/01/22.
The round was led by Andera Partners, derek dirocco.
